Biobanking Victoria - Precision Medicine Services

Biobanking
Biobanking Victoria supports a wide range of research and commercial activities that require the collection, processing, storage and or analysis of biological material. The facility utilises automated instrumentation and a laboratory information system to effectively manage samples at international standards.

Biobanking Victoria is a Monash University initiative supported by the Victorian State Government.  The facility has been developed by the Precision Medicine team in the School of Clinical Sciences at Monash Health in collaboration with RUCDR Infinite Biologics, New Jersey. Operating at international commercial standards, Biobanking Victoria can engage with a broad scope of activities that seek support with the collection, handling, storage and or analysis of biological material.   The facility has been designed to be flexible so it can provide an end-to-end solution or a modular custom fit solution for a range of users.

Dedicated laboratory flows and a laboratory information management system (LIMS) supports the reception, processing and storage of a wide range of biological materials including blood, saliva, tumour and faecal material.  Automated laboratory instruments support blood fractionation, nucleic acid extraction, genotyping, DNA sequencing and quality control. Specialist laboratories facilitate histopathology, tissue culture and molecular analyses.

A custom-built annex provides secure, 24/7 monitored storage for biological material in auto-fill, liquid nitrogen tanks and in -80°C freezers.  An important attribute of the facility is to support the mobilisation of material from storage to downstream applications in clinical trials, research and other industrial applications. The facility supports specialist handling and shipping of biological material including international destinations.

Users of the facility include dry researchers such as epidemiologists and clinical and laboratory-based researchers who drive expert directed collection of material but do not have access to standardised material handling or a secure, monitored storage facility. The facility also supports clinical trials and anticipate commercial users as well as facilitating collaboration between researchers and industry that would otherwise not be possible.